


Pathologist 🔬at Taipei Veterans General Hospital, #Taiwan 🇹🇼 #pathology #cytopath #thyroid #endopath #ENTpath #GUpath 🏃🗻🤿🍳🏳️🌈


I’ll be speaking on “Consolidated Workup of Thyroid Neoplasia: Classification Updates and the Role of Biomarker Studies” at #IAP2026 on October 11, 8:00–10:00 AM, in Room 7. Looking forward to seeing many friends and colleagues in Fukuoka!

Fun time at the 2026 International Cytopathology Sumposium in #Taipei Thanks for our speakers for visiting @aakasharmand

Great salivary session at the inaugural #AFCS meeting in Hong Kong. Practical and educational! Thanks for all the excellent speakers and my co-chair @IvanaKholova Congratulations to @hkiap1986 for a very successful meeting!

Metastasis to thyroid -Common Pitfalls - Metastatic RCC misdiagnosed as primary follicular neoplasm - Metastatic well-differentiated adenocarcinoma as papillary thyroid carcinoma, for example metastatic lung adenocarcinoma (see pic 2-4) - Metastatic high grade carcinoma as poorly differentiated thyroid carcinoma (PDTC) or anaplastic thyroid carcinoma Dr. Hang #USCAP2026 #pathology #PathX #PathTwitter

***Intranodal thyroid inclusions*** 1. Predominantly smooth luminal borders 2. Absence of nuclear pseudoinclusions 3. Nuclear diameter not larger that two times of an adjacent lymphocyte 4. Negative for BRAF, VE1, HBME-1 and galectin-3 IHC They can coexist with metastatic PTC Diagnostic criteria based on WHO 2020 Head and Neck Tumors Dr. Hang #USCAP2026 #pathology #PathX #PathTwitter

Proceedings 2026 NASHNP Companion Meeting, San Antonio, TX, 3/22/26: It’s a Trap! Pitfalls in Thyroid Pathology: Mets or Not Mets? Yu-Che Chuang & Jen-Fan Hang rdcu.be/e8t2o #HeadNeckPathol #HNPJ #HeadandNeckPath #Pathology #ENTPath #PathologyTweet

Proceedings 2026 NASHNP Companion Meeting, San Antonio, TX, 3/22/26: It’s a Trap! Pitfalls in Thyroid Pathology: Mets or Not Mets? Yu-Che Chuang & Jen-Fan Hang rdcu.be/e8t2o #HeadNeckPathol #HNPJ #HeadandNeckPath #Pathology #ENTPath #PathologyTweet

Do you know an out-of-frame ALK fusion can resume its open reading frame through alternative translation start sites and generate functional kinase protein as a therapeutic target? Check out our new study from @NYCU_official published on @CellRepMed👇 cell.com/cell-reports-medici…

First #USCAP invited talk completed!Thanks again for the kind invitation by @NASHNPath. It was truly an honor to be included among these great speakers. Now I can finally relax and enjoy the rest of the meeting lol #USCAP2026 #thyroid #ENTPath
USCAP HN companion meeting. Join us in room 301B #hnpath #USCAP


I am very honored to be invited by @NASHNPath to give a talk on diagnostic pitfalls in #Thyroid #Pathology at @TheUSCAP 2026 next week. The talk is accompanied by a proceeding article that has just been published in @HeadNeckPathol.👇#ENTPath #EndoPath reurl.cc/K2AQ1q

A meta-analysis in @EndoPath examines the classification of pituitary neuroendocrine tumors (PitNETs) versus pituitary adenomas. Findings suggest PitNETs align more closely with neuroendocrine tumors based on DNA methylation data. bit.ly/4nJQDDm

We are delighted to announce that @HeadNeckPathol's IF is now 4.1 and it is 11 / 90 journals in the Pathology category. Congrats to the Editors-in-Chief and the editorial team and thank you for the hard work. Also thank you to the authors, reviewers and readers for your support.

Congrats to Cancer Cytopathology!

Big news! Endocrine Pathology now holds an Impact Factor of 14.7 - ranking us #2 out of 90 pathology journals. A huge thanks to our authors, reviewers, and readers. Submit your outstanding research and be part of the momentum!